Text resize: A A A

milestones

2000 | 2001 | 2002 | 2003 | 2005| 2006| 2007| 2008| 2009

The coming together of Dr. Reddy's and Cheminor is well timed. It enables us to set our aspirations higher. The merger will free up resources that will enable us to bring a sharper and stronger focus to our investments in innovation. We see this as being critical to our continued success and emergence as a truly global pharmaceutical company.

Dr. K. Anji Reddy
Founder Chairman, Dr.Reddy's

Dr. Reddy's Laboratories becomes India's third largest pharmaceutical company with the merger of Cheminor Drugs Limited, a group company

Dr. Reddy's becomes India's third largest pharmaceutical company with the merger of Cheminor Drugs Limed (CDL) a group company, on December 11, 2000. G.V. Prasad takes over as Executive Vice-Chairman and CEO, and Satish Reddy becomes the MD and COO of the merged entity.

The merger gives Dr. Reddy’s critical mass to compete, raise resources, attract and retain talent. It also enables the company to lower the risk inherent in some of its businesses- bulk drugs, generics, branded formulations, discovery and biotech. The merger results in significant synergies in common functions and businesses and the diversification in the portfolio enables Dr. Reddy’s to spread the risk.

Dr. Reddy's Foundation introduces LABS

LABS - Livelihood Advancement Business School, the flagship program of Dr. Reddy’s Foundation for Human and Social Development starts with nine children belonging to economically weaker sections of the society.

Click to read related memories

2000

LABS - the flagship program of
Dr. Reddy’s Foundation for Human and Social Development